DBCCR1 gene therapy (Gendux)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameDBCCR1 gene therapy (Gendux)
Drug Alias Namebladder cancer therapy (Gendux)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGendux Molecular Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGendux Molecular Ltd
Active IndicationsN/A
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A